Clinical trial
Dexamethasone, Olanzapine, Flow-targeted Versus Pressure-targeted Hemodynamic Management, and Low Tidal Volume Ventilation in Patients Undergoing On-pump Cardiac Surgery - a Multifactorial Design Randomized Trial
NCT05635227 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexamethasone, Olanzapine, Flow-targeted Versus Pressure-targeted Hemodynamic Management, and Low Tidal Volume Ventilation in Patients Undergoing On-pump Cardiac Surgery - a Multifactorial Design Randomized Trial
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 10, 2022
- Completion date
- February 29, 2028
- Enrollment
- 1,200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.